Tom. you, Thank
quarter at + share and overall highlights like results excluding Bausch for some I Bausch Health, the our from segment review we would Before fourth the to level, Lomb.
about million or business X% flow demonstrating to The was growth when was expense Adjusted thanks our with benefits, from exceptional. of year-over-year cash cash Revenues or billion, our of EBITDA for year and flow in to a year of increase Adjusted the for growing excluding addition unusually timing in the $X.X onetime a were year mix. the QX. operating were, business taxes drivers X% $X.XXX tight model, and $XXX $X XXXX continued the was these of the from and billion for XX% which Even was full or billion primary our leverage operational management year-over-year, growth million. outflows performance, XX% a approximately positive some adjusted $X.XXX low year-over-year. operation cash in operations
starting of which an consolidated on full Revenue a basis. quarter X% versus performance billion, performance and organic billion, XXXX for was the points ago. up on segment basis XX an XX. our $X.XXX same review increase higher reported organic gross and year basis a a more the and now an the for me year for our detail fourth quarter X% reported Adjusted on was with basis was same X% ago. on the the on XX% a by overall Let Page than $X.XXX in quarter period XX.X%, fourth was basis year Revenue margin
was of full versus an increase XXXX. XX.X%, the For XX points basis year, it
for million year. the of million, the same over were expenses increase fourth operating Adjusted last $XX quarter $XXX an period
For the of year-over-year. $XX R&D expenses for expense year-over-year. or Adjusted million, a was billion full $XXX increase increase $X.XXX quarter million operating XX% year, which was an the were
expense X%. R&D of adjusted full million or increase year, an $XXX was the For
Adjusted EBITDA the in $X.XXX $XXX billion was full QX year. million for and
full was million in operating fourth and adjusted consolidated cash flow, a still $XXX for Finally, quarter $X.XXX on basis, billion year. the
$XXX $X.XXX the basis Focusing same excluding on Lomb. quarter X% organic Health, an X% was now for was Revenue $X.XXX from million, a full on of on basis on and of on an fourth quarter up was billion, basis organic billion, XXXX. versus ago. Adjusted a the year X% increase reported of X% year the reported and quarter Revenue EBITDA performance the increase an Bausch fourth X% for a the Bausch basis. + a
was increase full $X.XXX an the it of X%. For or year, billion
generation by second, in up driven taxes; up some operating $XXX when $XXX favorable X adjusted outflows the in cash cash operating The and factors: segments; of first on third, timing and quarter our flow was XXXX. when performance to Adjusted in $X.XXX primarily were of operating million fourth was our QX. cash the billion, the of compared and well-balanced $XXX fourth overall flow a flow XXXX unusually low cash a across quarter foremost, million, full basis, XXXX. impressive year And million compared to
quarter Salix performance year-over-year, our by grew an revenues Salix segment, of XX. driven $XXX Page which to million or primarily were by now an X% million fourth fourth growth Turning starting quarter in increase Xifaxan, XX%. the with $XX outstanding on
such and deployment. scripts the Xifaxan specifically, optimization trend following be scripts to were More fourth again our outpatient which our encouraged both clinics, by for X% continue units force of hospitals sales grew nonretail in and recent double-digit selling includes new the quarter. growth Extended script strong total growth. X% We saw the of up as
Page the growth of was Now for organic and International of moving X% on difference on quarter, last basis $XXX decrease were dollar basis Revenues driven a of to X% increase the fourth by the against reported peso. The X% the mostly quarter an of strengthening International year. of segment a to XX. on an the during compared the million Mexican
EMEA excluding Also a on worth benefit organic noting continued and and X% the the reported Revenues impact our strongest on in to the our grew Canada reported of promoted by in XX% competitor is the in on driven the which across and quarter. were when double-digit basis Revenue our growth Wellbutrin EMEA generic deployment growth products of sales supply a reflects benefits in broad X% of Canada a optimization geography, X% of market. commercialized By contributors Canada, shortage the an grew portfolio products. FX. of basis the basis, in
on basis, America, timing of mostly year-over-year Finally, due in an Mexico. XX% decreased revenue government the in Latin to organic tenders
segment. This capped for moving XX Solta were fourth during Page our Solta to both quarter, review our be on XX% Now the of Korea million segment was profit. reported more country, $XXX basis. increase Revenues What an to an Solta By Medical for drivers and revenue even China outstanding primary the year primarily volume. a impressive continue that driven and globally. growth Solta's South was Solta growth to for is of by for
term. As since positioned of which performed believe is sustained well. relaunched in exceptionally Thermage quarter long this FLX well for in second China, near has a the business we reminder, growth year, and We the this in
segments, will fourth were million Page our focus during decrease of Turning a now quarter, the of Revenues reported diversified XX. basis. a performance diversified for you which segments on the XX% on to our find the $XXX
fourth year, results As impacting marketplace that overall prior last we generic on quarter supply the shortage supply capitalize on Ativan. in allowed to reminder, This recur a year. constraint our year, the versus this call quarter sales of not did us referenced
me briefly $X.XXX XX Page line during wrap segment a top the up on XX. were discussion billion the Bausch fourth reported on Revenues Lomb commenting fourth + by for let quarter, Finally, quarter the X% basis. up results and on
For year the year, reported versus were revenues the XX% a increase an $X.XXX billion, prior basis. full on of
starting our now Turning sheet, Page with XX. balance to
flow our we cash net Bausch of excluding + in Bausch of Lomb, reduced exceptional million. QX, $XXX by cash performance Health, result approximately debt a our As for
first, the For and settlements, obligations. almost the half; $XXX by compared stood restructuring million on in by where million to purchases $XXX to of continue full cash amortization per hand end to our second, market the year actions: loan and these primarily of our through with $X This $XXX allowed balance our XXXX. all increase an and million $XXX of after our as payments consequence amounted when to associated executed gross legal was the us X debt net The billion. about reduce by first at reduce reduction we we open XXXX drivers million term annual we mandatory of debt
an as X outstanding resilient strong of segments. continue we to of our capped Overall, operating year assets fourth on a was optimize the quarter of for finish Bausch Health We all return and set in that fronts positioned all are believe we XXXX. off for the year across diversified well another strong performance
you Bausch provide Page now XXXX our which guidance on me Bausch financial Let XX. will you find excluding with Health, for Lomb, +
expected the midpoint be For XXXX. a into billion. billion $X.XXX between versus expect increase of we XXXX, that year-over-year. billion billion $X.XXX to between $X.XXX translate and a Adjusted $X.XXX would X% and The increase is be X% revenues EBITDA making to range midpoint
Finally, and from million billion. expect be we $XXX cash adjusted between operations flow $X.XXX to
year-over-year, taxes reduction level working cash given the of XXXX. and represents onetime cash flow recorded generation changes $XXX benefits a a into in translate we million of this it sustainable capital Although more
creation Tom for Before primary review let still looking remarks, Page will I hand that our for X back it his creation levers value performance our Bausch there by me in framework we last progress value for at to shareholders. We on XX. are end introduced to believe quarter, relation Health which find you concluding this
as our high-performing Health focus strongly first is leadership the our XXXX. increase performance have we broad The evidenced by a of assets is We the one Bausch outstanding of to our value set team. of primary believe This in portfolio.
speaks grown a to Tom our and of row have and bottom resiliency we line performance quarter our the top is consistency seventh in growth earlier, our this As indicated strategy. and the
highlights leverage expense high has the tight intensity It are our capital of low, free more, management. flows. through producing model our also business strong because What's business our operating business positive mix been and cash margins and our is
Bausch + the maximize of value Health asset lever Bausch is for to second our Our shareholders. Lomb
the + at Lomb Bausch the Bausch Health most the value. the has reflected least shareholders. now from Health accretive Bausch Bausch indicated an not Bausch objective we of of + to ago, long-term to as that Lomb exploration same, lead way + weeks the in Lomb main is it which selling Nevertheless, As concluded, remains offer complete X did for separation for
to We options and evaluate so. to all will any do continue
And lastly, capital our we optimize third lever our is that have October. to progress structure. made effect, good To last since
by million the with which our which and we allowed an need additional our XXXX our need facility, our XXXX reduce have billion XXXX. address flexibility. First maturity for our expect net $X increase has and cash resources during $XXX will $XXX without access debt additional up cash the debt almost accelerated facility, foremost, financial generation generation, facility, to new flow a quarters, Separately, anticipated facility operational and credit together With of this have our we to hand, we over sources million funding. both we the X to free credit cash secured next have on our to commitment flow and obligations AR all to us our
we of addressing are In look many conclusion, on the forward beyond as But on maturities. an with tremendous that XXXX. the the XXXX, first the capital XXXX milestone successful in half we improvement towards Bausch and include a is another year done by which plan to of in shares tapping in progress made could have capital we the owned + important we fronts not pledging effect, portion Lomb Obviously, structure XXXX To our and markets this our redirect focus efforts. company.
now hand Tom wrap-up. for to back it the will I
